Standout Papers

Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer 2024 202696
  1. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer (2024)
    Xueqi Ou, Yeru Tan et al. Drug Resistance Updates

Immediate Impact

1 by Nobel laureates 50 standout
Sub-graph 1 of 25

Citing Papers

Pre-metastatic niche: formation, characteristics and therapeutic implication
2024 Standout
Multifunctional nanoparticle-mediated combining therapy for human diseases
2024 Standout
2 intermediate papers

Works of Yeru Tan being referenced

Long noncoding RNA cancer susceptibility candidate�9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2
2018

Author Peers

Author Last Decade Papers Cites
Yeru Tan 253 173 64 25 329
Guifang Yu 239 168 38 18 357
Yizhe Wang 187 119 77 23 296
Qiangnu Zhang 257 202 62 23 334
Zongjiang Luo 248 231 45 19 315
Zhangxiang Zhao 192 151 64 24 275
Yu Xiong 222 111 52 32 340
Xiaoping Wu 267 251 30 18 346
Juanfei Peng 212 155 42 13 277
Zhou‐Tong Dai 225 145 42 26 348
Haitao Lan 189 135 52 21 310

All Works

Loading papers...

Rankless by CCL
2026